Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

AC Spyropoulos, SL Cohen, E Gianos… - … and practice in …, 2021 - Wiley Online Library
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to …

To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients

AC Spyropoulos - Hematology, 2022 - ashpublications.org
The field of thromboprophylaxis for acutely ill medical patients, including those hospitalized
for COVID-19, is rapidly evolving both in the inpatient setting and the immediate post …

Extended post-discharge thromboprophylaxis in hospitalized COVID-19 patients

AC Spyropoulos - Expert Review of Hematology, 2022 - Taylor & Francis
Introduction Hospitalized COVID-19 patients, particularly those with high-risk features, are at
risk for venous and arterial thromboembolic events for approximately 30 days or more after …

Universal EHRs clinical decision support for thromboprophylaxis in medical inpatients: a cluster randomized trial

AC Spyropoulos, M Goldin, I Koulas, J Solomon, M Qiu… - JACC: Advances, 2023 - jacc.org
Background Thromboprophylaxis for medically ill patients during hospitalization and
postdischarge remains underutilized. Clinical decision support (CDS) may address this …

A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infection

M Beckman, S Nyrén, A Kistner - Thrombosis journal, 2020 - Springer
Background Pulmonary embolism (PE) is seen in high frequency in hospital-treated patients
with Covid-19. We present a case of suspected Covid-19 with long-term dyspnea and …

Predictive scoring models for persistent gram-negative bacteremia that reduce the need for follow-up blood cultures: a retrospective observational cohort study

J Jung, KH Song, KI Jun, CK Kang, NH Kim… - BMC infectious …, 2020 - Springer
Background Although the risk factors for positive follow-up blood cultures (FUBCs) in gram-
negative bacteremia (GNB) have not been investigated extensively, FUBC has been …

Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID‐19: Multicentre observational study in the UK

DJ Arachchillage, I Rajakaruna, Z Odho… - British Journal of …, 2023 - Wiley Online Library
Post‐discharge thromboprophylaxis in patients admitted with COVID‐19 remains
controversial. We aimed to determine the impact of thromboprophylaxis on hospital acquired …

VTE prophylaxis therapy: clinical practice vs clinical guidelines

AD Abukhalil, A Nasser, H Khader… - Vascular Health and …, 2022 - Taylor & Francis
Introduction Venous thromboembolism (VTE) is the most preventable complication in
hospitalized patients. The main objective of this study was to evaluate the adherence of …

[HTML][HTML] Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving …

G Le Gal, G Agnelli, H Darius, SR Kahn… - European Journal of …, 2024 - Elsevier
Background We aimed to describe the event rates and risk-factors for symptomatic venous
thromboembolism (VTE) and major bleeding in a population of hospitalized acutely ill …

Improving thromboprophylaxis in the medical inpatients: The role of the resident in an academic hospital

FJ Torres-Quintanilla, JR Azpiri-López… - …, 2023 - journals.sagepub.com
Introduction Venous thromboembolism (VTE) is one of the main causes of preventable in-
hospital death. It is recommended for hospitals to have an appropriate thromboprophylaxis …